ClinicalTrials.Veeva

Menu
Washington University School of Medicine in St. Louis | Washington University Therapeutics (WT) CRS logo

Washington University School of Medicine in St. Louis | Washington University Therapeutics (WT) CRS

Research site

Site insights

Top conditions

Top treatments

TDF
Maraviroc
Raltegravir
FTC
Cabotegravir
Pramipexole
d4T
Nucleoside
NVP
Tenofovir Disoproxil Fumarate

Parent organization

This site is a part of Washington University School of Medicine in St. Louis

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Contact ID CRU about Studies

Verified by this site

Active trials

4 of 38 total trials

Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1

The purpose of this study is to evaluate the safety, tolerability, and efficacy of therapeutic vaccination with chimpanzee adenovirus ChAdOx1- and po...

Enrolling
HIV-1-infection
Biological: MVA.tHIVconsv3
Biological: Placebo

A phase II, randomized, open-label, two-arm clinical trial evaluating the safety and efficacy of pramipexole extended release (ER) versus escitalopra...

Not yet enrolling
Major Depressive Disorder
Mild Neurocognitive Disorder
Drug: Escitalopram
Drug: Pramipexole ER

The purpose of this study is to evaluate the safety, tolerability, and efficacy of N-803, an IL-15 superagonist, with or without combination broadly...

Active, not recruiting
HIV Infection
Biological: 10-1074
Biological: N-803 (IL-15 Superagonist)

The purpose of this study was to compare the efficacy, safety, and durability of two different strategies to treat participants with a history of sub...

Active, not recruiting
HIV Infections
Drug: CAB-LA Loading Dose
Drug: RPV-LA Maintenance Dose

Trial sponsors

National Institute of Allergy and Infectious Diseases (NIAID) logo
A
Boehringer Ingelheim logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems